Fig. 2
Progression-free survival (a) and overall survival (b) according to presence/absence of refractory disease at baseline. OS overall survival, PFS progression-free survival
Fig. 2 | Signal Transduction and Targeted Therapy
Progression-free survival (a) and overall survival (b) according to presence/absence of refractory disease at baseline. OS overall survival, PFS progression-free survival
